The Vital Role Of Start-Ups In Medtech Innovation
The MDR Threatens To Drive EU Start-ups To The US And The Outstanding EU MRA Is A Further Hurdle For Swiss Medtech Innovators
Executive Summary
Focus On Switzerland – Part 4: The fragile nature of start-ups belies their value in medtech innovation, and they do not need unnecessary regulatory complications.